{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T23:40:07Z","timestamp":1749253207171,"version":"3.41.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2023GGA056"],"award-info":[{"award-number":["2023GGA056"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funding for Investigator-Initiated Clinical Trials","award":["202413004"],"award-info":[{"award-number":["202413004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Primary malignant melanoma of the vagina (PMMV) and cervix (PMMC) are extremely rare tumors with a poor prognosis, lacking well-defined protocols or standardized treatment guidelines. While the preferred management for early-stage PMMV and PMMC is surgery, comprehensive reports on the impact of various surgical techniques on cancer outcomes are scarce.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study aimed to compare outcomes between open and minimally invasive surgery (MIS) in PMMV and PMMC, and concurrently evaluated prognostic risk factors for these conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a single-center retrospective cohort study of PMMV and PMMC patients treated surgically from January 2000 to July 2021. Clinicopathological features and surgical outcomes were assessed retrospectively. Patients underwent either open surgery or MIS. Disease-Free Survival (DFS) rates were compared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 45 eligible patients, the MIS group showed a higher rate of total vaginectomy (<jats:italic>P<\/jats:italic>\u2009=\u20090.022), reduced median intraoperative blood loss (<jats:italic>P<\/jats:italic>\u2009=\u20090.031), shorter median hospital stay (<jats:italic>P<\/jats:italic>\u2009=\u20090.042), and no significant increase in perioperative complications (<jats:italic>P<\/jats:italic>\u2009=\u20090.867). The incidence of negative margins\u2009&lt;\u20091\u00a0cm was significantly lower in the MIS group (<jats:italic>P<\/jats:italic>\u2009=\u20090.032). Cox proportional hazards regression identified microsatellites (HR\u2009=\u20092.893 [1.042\u20138.029]; <jats:italic>P<\/jats:italic>\u2009=\u20090.042), surgical negative margin distance (HR\u2009=\u20090.042 [0.008\u20130.217]; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and total vaginectomy (HR\u2009=\u20090.042 [0.008\u20130.217]; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) as independent prognostic factors for DFS. MIS was linked to a significant difference in 2-year DFS (<jats:italic>P<\/jats:italic>\u2009=\u20090.030), but there was no notable difference in overall survival (OS) compared to open surgery (<jats:italic>P<\/jats:italic>\u2009=\u20090.078). The outcomes are validated through sensitivity analysis and hierarchical assessment, leading to the development of a novel nomogram simultaneously.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Total vaginectomy may improve DFS in PMMV and PMMC patients. A combination of MIS and radical vaginal resection can effectively manage PMMV and PMMC as an initial surgical strategy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03760-x","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:18:45Z","timestamp":1749208725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical practice and outcomes of minimally invasive surgery in primary malignant melanoma of the vagina and cervix patients: a retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Bin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haizhou","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9421-9418","authenticated-orcid":false,"given":"Cuibo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"6","key":"3760_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/CMR.0000000000000480","volume":"28","author":"O Saglam","year":"2018","unstructured":"Saglam O, Naqvi SMH, Zhang YH, Mesa T, Teer JK, Yoder S, et al. Female genitourinary tract melanoma: mutation analysis with clinicopathologic correlation: a single-institution experience. Melanoma Res. 2018;28(6):586\u201391.","journal-title":"Melanoma Res"},{"issue":"6","key":"3760_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jogc.2018.07.011","volume":"41","author":"SE Sinasac","year":"2019","unstructured":"Sinasac SE, Petrella TM, Rouzbahman M, Sade S, Ghazarian D, Vicus D. Melanoma of the Vulva and Vagina: surgical management and outcomes based on a clinicopathologic review of 68 cases. J Obstet Gynaecol Can. 2019;41(6):762\u201371.","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"3760_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1006\/gyno.2001.6337","volume":"83","author":"WP Irvin Jr","year":"2001","unstructured":"Irvin WP Jr, Legallo RL, Stoler MH, Rice LW, Taylor PT Jr, Andersen WA. Vulvar melanoma: a retrospective analysis and literature review. Gynecol Oncol. 2001;83(3):457\u201365.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"3760_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/ijgc-00009577-200109000-00004","volume":"11","author":"CF Verschraegen","year":"2001","unstructured":"Verschraegen CF, Benjapibal M, Supakarapongkul W, Levy LB, Ross M, Atkinson EN, et al. Vulvar melanoma at the M. D. Anderson Cancer Center: 25\u00a0years later. Int J Gynecol Cancer. 2001;11(5):359\u201364.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"3760_CR5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/0002-9378(94)90137-6","volume":"171","author":"MA Weinstock","year":"1994","unstructured":"Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol. 1994;171(5):1225\u201330.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3760_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ygyno.2013.02.028","volume":"129","author":"JM Janco","year":"2013","unstructured":"Janco JM, Markovic SN, Weaver AL, Cliby WA. Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy. Gynecol Oncol. 2013;129(3):533\u20137.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"3760_CR7","first-page":"4017","volume":"10","author":"D Wang","year":"2020","unstructured":"Wang D, Xu T, Zhu H, Dong J, Fu L. Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management. Am J Cancer Res. 2020;10(12):4017\u201337.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"3760_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/CMR.0000000000000239","volume":"26","author":"Y Todo","year":"2016","unstructured":"Todo Y, Okamoto K, Suzuki Y, Minobe S, Kato H. Radicality of initial surgery for primary malignant melanoma of the vagina. Melanoma Res. 2016;26(2):173\u201380.","journal-title":"Melanoma Res"},{"issue":"12","key":"3760_CR9","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1001\/jama.2017.2068","volume":"317","author":"M Janda","year":"2017","unstructured":"Janda M, Gebski V, Davies LC, Forder P, Brand A, Hogg R, et al. Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial. JAMA. 2017;317(12):1224\u201333.","journal-title":"JAMA"},{"issue":"6","key":"3760_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.asjsur.2021.09.023","volume":"45","author":"JH Ahn","year":"2022","unstructured":"Ahn JH, Park DC, Yoon JH, Lee SJ, Cha J, Yoo JG, et al. Oncologic safety of minimally invasive surgery in non-endometrioid endometrial cancer. Asian J Surg. 2022;45(6):1253\u20138.","journal-title":"Asian J Surg"},{"issue":"11","key":"3760_CR11","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/jjco\/hyab128","volume":"51","author":"K Nakagawa","year":"2021","unstructured":"Nakagawa K, Yoshida Y, Yotsukura M, Watanabe SI. Minimally invasive open surgery (MIOS) for clinical stage I lung cancer: diversity in minimally invasive procedures. Jpn J Clin Oncol. 2021;51(11):1649\u201355.","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"3760_CR12","first-page":"1664","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer Interdiscip Int J Am Cancer Soc. 1998;83(8):1664\u201378.","journal-title":"Cancer Interdiscip Int J Am Cancer Soc"},{"issue":"6","key":"3760_CR13","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.4103\/jcrt.JCRT_893_15","volume":"15","author":"S Puri","year":"2019","unstructured":"Puri S, Asotra S. Primary vaginal malignant melanoma: a rare entity with review of literature. J Cancer Res Ther. 2019;15(6):1392\u20134.","journal-title":"J Cancer Res Ther"},{"issue":"5","key":"3760_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2021.102091","volume":"50","author":"M Joste","year":"2021","unstructured":"Joste M, Dion L, Brousse S, Nyangoh Timoh K, Rousseau C, Reilhac A, et al. Vulvar and vaginal melanomas: a retrospective study spanning 19 years from a tertiary center. J Gynecol Obstet Hum Reprod. 2021;50(5): 102091.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"15","key":"3760_CR15","doi-asserted-by":"publisher","first-page":"e22106","DOI":"10.1200\/JCO.2020.38.15_suppl.e22106","volume":"38","author":"S Nishio","year":"2020","unstructured":"Nishio S, Ogata D, Kiyohara Y, Takekuma M, Mikami M, Usami T, et al. Clinicopathological demographics of malignant melanoma of the vulva and vagina in Japan: Japanese gynecologic oncology group (JGOG)\/Japanese Skin Cancer Society (JSCS)-intergroup study. J Clin Oncol. 2020;38(15):e22106.","journal-title":"J Clin Oncol"},{"key":"3760_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ygyno.2020.05.609","volume":"159","author":"C Wohlmuth","year":"2020","unstructured":"Wohlmuth C, Wohlmuth-Wieser I, May T, Vicus D, Gien LT, Laframboise S. Malignant melanoma of the vulva and vagina: a study of 1863 cases. Gynecol Oncol. 2020;159:332\u20133.","journal-title":"Gynecol Oncol"},{"issue":"13","key":"3760_CR17","doi-asserted-by":"publisher","first-page":"14052","DOI":"10.1002\/cam4.6054","volume":"12","author":"Y Ye","year":"2023","unstructured":"Ye Y, Fu A, Cai J, Ma Z, Chen Y, Zou X, et al. Primary malignant melanoma of the cervix: a comprehensive analysis of case reports in the Chinese population. Cancer Med. 2023;12(13):14052\u201361.","journal-title":"Cancer Med"},{"issue":"20","key":"3760_CR18","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","volume":"379","author":"PT Ramirez","year":"2018","unstructured":"Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895\u2013904.","journal-title":"N Engl J Med"},{"issue":"6","key":"3760_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1470-2045(20)30081-4","volume":"21","author":"M Frumovitz","year":"2020","unstructured":"Frumovitz M, Obermair A, Coleman RL, Pareja R, Lopez A, Ribero R, et al. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2020;21(6):851\u201360.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3760_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.23736\/S2724-606X.20.04726-7","volume":"73","author":"G Bogani","year":"2021","unstructured":"Bogani G, di Donato V, Chiappa V, Lopez S, Monti M, Muzii L, et al. Minimally invasive surgery in cervical cancer. Minerva Obstet Gynecol. 2021;73(2):145\u20138.","journal-title":"Minerva Obstet Gynecol"},{"issue":"2","key":"3760_CR21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3390\/curroncol29020093","volume":"29","author":"O Touhami","year":"2022","unstructured":"Touhami O, Plante M. Minimally invasive surgery for cervical cancer in light of the LACC trial: what have we learned? Curr Oncol. 2022;29(2):1093\u2013106.","journal-title":"Curr Oncol"},{"issue":"13","key":"3760_CR22","doi-asserted-by":"publisher","first-page":"8320","DOI":"10.1245\/s10434-022-12356-9","volume":"29","author":"F Siegenthaler","year":"2022","unstructured":"Siegenthaler F, Johann S, Imboden S, Samartzis N, Ledermann-Liu H, Sarlos D, et al. Prospective multicenter trial assessing the impact of positive peritoneal cytology conversion on oncological outcome in patients with endometrial cancer undergoing minimally invasive surgery with the use of an intrauterine manipulator\u202f: positive peritoneal cytology conversion and its association with oncological outcome in endometrial cancer. Ann Surg Oncol. 2022;29(13):8320\u201333.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"3760_CR23","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1097\/IGC.0b013e3182a1ced8","volume":"23","author":"AN Kirschner","year":"2013","unstructured":"Kirschner AN, Kidd EA, Dewees T, Perkins SM. Treatment approach and outcomes of vaginal melanoma. Int J Gynecol Cancer. 2013;23(8):1484\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"3760_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pathol.2021.05.094","volume":"54","author":"LA Jackett","year":"2022","unstructured":"Jackett LA, Satgunaseelan L, Roper E, Lo SN, Thompson JF, Scolyer RA. Residual melanoma in wide local excision specimens after \u2018complete\u2019 excision of primary cutaneous in situ and invasive melanomas. Pathology. 2022;54(1):71\u20138.","journal-title":"Pathology"},{"key":"3760_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jdin.2022.06.001","volume":"8","author":"L Gaetano","year":"2022","unstructured":"Gaetano L, Domenico B, Lo SN, Hamed T, Potter AJ, Thompson JF, et al. Association between excision margins and local recurrence in 1407 patients with primary in situ melanomas. JAAD Int. 2022;8:102\u20138.","journal-title":"JAAD Int"},{"issue":"2","key":"3760_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jaad.2017.03.025","volume":"77","author":"CJ Miller","year":"2017","unstructured":"Miller CJ, Shin TM, Sobanko JF, Sharkey JM, Grunyk JW, Elenitsas R, et al. Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas. J Am Acad Dermatol. 2017;77(2):333-40.e1.","journal-title":"J Am Acad Dermatol"},{"key":"3760_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2023.101266","volume":"49","author":"G Sticca","year":"2023","unstructured":"Sticca G, Misheva B, Sebajang H, Samouelian V, Jamal R. Primary malignant melanoma of the vagina: a case report. Gynecol Oncol Rep. 2023;49: 101266.","journal-title":"Gynecol Oncol Rep"},{"issue":"6","key":"3760_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/diseases12060126","volume":"12","author":"D Dealberti","year":"2024","unstructured":"Dealberti D, Bosoni D, Spissu F, Pisani C, Pizio C, Nappi L, et al. Primary malignant melanoma of the endocervix uteri and outpatient hysteroscopy as a diagnostic tool: case report and literature overview. Diseases. 2024;12(6):126.","journal-title":"Diseases"},{"key":"3760_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jmig.2024.12.008","volume":"32","author":"D Dealberti","year":"2024","unstructured":"Dealberti D, Bosoni D, Spissu F, Stabile G. Primary malignant melanoma of the endocervix uteri: hysteroscopic view and diagnosis of a rare yet very aggressive entity. J Minim Invas Gyn. 2024;32:314\u20135.","journal-title":"J Minim Invas Gyn"},{"issue":"17","key":"3760_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025691","volume":"100","author":"N Guo","year":"2021","unstructured":"Guo N, Zhang J. Primary vaginal malignant melanoma: a rare case report of successful treatment with nivolumab. Medicine (Baltimore). 2021;100(17): e25691.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3760_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/jog.14136","volume":"46","author":"M Anko","year":"2020","unstructured":"Anko M, Nakamura M, Kobayashi Y, Tsuji K, Nakada S, Nakamura Y, et al. Primary malignant melanoma of the uterine cervix or vagina which were successfully treated with nivolumab. J Obstet Gynaecol Res. 2020;46(1):190\u20135.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"3760_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/03007995.2019.1662688","volume":"36","author":"S Shah","year":"2020","unstructured":"Shah S, Raskin L, Cohan D, Freeman M, Hamid O. Treatment patterns of malignant melanoma in the United States from 2011 to 2016: a retrospective cohort study. Curr Med Res Opin. 2020;36(1):63\u201372.","journal-title":"Curr Med Res Opin"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03760-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T23:01:55Z","timestamp":1749250915000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03760-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3760"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03760-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Fujian Cancer Hospital\u2019s ethics committee on September 10, 2023. Approval number: K2023-246\u201301.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest or financial ties to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}